188 related articles for article (PubMed ID: 15893774)
1. Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor.
Garai J; Lóránd T; Molnár V
Life Sci; 2005 Aug; 77(12):1375-80. PubMed ID: 15893774
[TBL] [Abstract][Full Text] [Related]
2. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
Garai J; Molnár V; Eros D; Orfi L; Lóránd T
Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP
Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941
[TBL] [Abstract][Full Text] [Related]
5. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.
El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA
Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113
[TBL] [Abstract][Full Text] [Related]
6. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.
Lubetsky JB; Swope M; Dealwis C; Blake P; Lolis E
Biochemistry; 1999 Jun; 38(22):7346-54. PubMed ID: 10353846
[TBL] [Abstract][Full Text] [Related]
7. Plant-derived anti-inflammatory compounds affect MIF tautomerase activity.
Molnar V; Garai J
Int Immunopharmacol; 2005 May; 5(5):849-56. PubMed ID: 15778121
[TBL] [Abstract][Full Text] [Related]
8. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.
Cheng KF; Al-Abed Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.
Orita M; Yamamoto S; Katayama N; Fujita S
Curr Pharm Des; 2002; 8(14):1297-317. PubMed ID: 12052220
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-inducible uterine flavonoid binding sites: is it time to reconsider?
Garai J; Adlercreutz H
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):377-81. PubMed ID: 15145447
[TBL] [Abstract][Full Text] [Related]
11. Ionization state and molecular docking studies for the macrophage migration inhibitory factor: the role of lysine 32 in the catalytic mechanism.
Soares T; Goodsell D; Ferreira R; Olson AJ; Briggs JM
J Mol Recognit; 2000; 13(3):146-56. PubMed ID: 10867710
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor.
Bendrat K; Al-Abed Y; Callaway DJ; Peng T; Calandra T; Metz CN; Bucala R
Biochemistry; 1997 Dec; 36(49):15356-62. PubMed ID: 9398265
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution.
Sugimoto H; Taniguchi M; Nakagawa A; Tanaka I; Suzuki M; Nishihira J
Biochemistry; 1999 Mar; 38(11):3268-79. PubMed ID: 10079069
[TBL] [Abstract][Full Text] [Related]
14. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase.
Kleemann R; Kapurniotu A; Frank RW; Gessner A; Mischke R; Flieger O; Jüttner S; Brunner H; Bernhagen J
J Mol Biol; 1998 Jul; 280(1):85-102. PubMed ID: 9653033
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor (MIF)--its role in catecholamine metabolism.
Matsunaga J; Sinha D; Solano F; Santis C; Wistow G; Hearing V
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1035-40. PubMed ID: 10644007
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor by 2-oxo-4-phenyl-3-butynoate.
Golubkov PA; Johnson WH; Czerwinski RM; Person MD; Wang SC; Whitman CP; Hackert ML
Bioorg Chem; 2006 Aug; 34(4):183-99. PubMed ID: 16780921
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments.
Garai J; Lóránd T
Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor.
Stamps SL; Fitzgerald MC; Whitman CP
Biochemistry; 1998 Jul; 37(28):10195-202. PubMed ID: 9665726
[TBL] [Abstract][Full Text] [Related]
19. Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.
Trivedi-Parmar V; Jorgensen WL
J Med Chem; 2018 Sep; 61(18):8104-8119. PubMed ID: 29812929
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
Senter PD; Al-Abed Y; Metz CN; Benigni F; Mitchell RA; Chesney J; Han J; Gartner CG; Nelson SD; Todaro GJ; Bucala R
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):144-9. PubMed ID: 11773615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
